You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A new study finds a genetic variation linked to ADHD that also predicts which children will outgrow the disorder.
Keith Robison remembers the early days of restriction endonucleases.
Another cloning first: a fourth-generation cloned pig.
Personalized medicine? This article says so-called ethnic drugs don't treat based on true genetic variation among individuals.
Chris Mooney says preconceptions, not critical thinking, drives the Bush administration's stance on science.
A blogger asks for pictures of his readers' science-related tattoos.
Drug companies stand to gain by funding biomedical research.
A blogger links to a ballad on polony sequencing. Forgive us.
Jonathan Eisen blogs on why medical professionals should get more evolution education than most medical schools currently offer.
Scientists recovered 60-million-year-old microbes from an Antarctic glacier -- and woke them up.
Score one for subscription-based publications: this blog post details an open-access trial that didn't work out.
NSF looks set to award IBM a contract to build the world's fastest supercomputer.
Fred Sanger bequeaths his collection of lab notebooks to the Wellcome Trust to make them available to the public.
Despite great funding, an embryonic stem-cell research program in California is having trouble finding a president.
Disgraced stem cell scientist didn't realize he'd made parthenogenic stem cells.
The NIH asks for ideas about peer review.
Today's Science reports on immunology, patient identifiability in genomic research, synthetic biology, and more.
Creationists and engineers do virtual battle...again.
A computer program from UVA aims to predict which cancer drug is best for each patient.
A blogger says the antiquated way that authorship order is decided for publications has to go.
A new application can browse the genome in interactive real-time.
Mice, cancer, and the epigenome are all in this week's issue of Nature.
A blogger muses on what life would be like if we could debug the human body.
Harvard loses $350 million by investing in the wrong hedge fund.
Jason Bobe suggests creating a Richter-esque scale for genome association study data.
According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.
A number of United Nations agencies push for scientific findings to be made accessible through open science.
Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.
In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.